1) Schöffski P et al. Eribulin versus dacarbazine in previously treated patients with
advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3
trial. The Lancet. 2016.
2) Cancer Research UK, Soft Tissue Sarcoma Incidence Statistics. Available at:
http://www.cancerresearchuk.org/cancer-info/cancerstats/type...
Accessed: November 2015
3) Young R, Woll P. Eribulin - a new active agent for L-sarcoma. The Lancet. 2016
4) Macmillan. What are soft tissue sarcomas? Available at:
http://www.macmillan.org.uk/Cancerinform...
. Accessed: November 2015
5) Fletcher et al. World Health Organization Classification of Tumours of Soft Tissue and
Bone (4th Edition). Lyon: IARC Press, 2013
6) ESMO Guidance. Available at:
http://annonc.oxfordjournals.org/content... Accessed:
November 2015
7) National Cancer Institute. Available at:
http://www.cancer.gov/cancertopics/pdq/treatment/adult-soft-...
. Accessed November 2015
8) Matsuda S., et al. Soft-Tissue Sarcoma Surveillance Counterpoint: Japan. Current
Clinical Oncology. 2013; 233-34
9) Tsujii H, et al. Carbon-Ion Radiotherapy: Principles, Practices, and Treatment
Planning. Springer. 2014; (XII)312:37
10) SPC Halaven (updated November 2015). Available at:
http://www.medicines.org.uk/emc/medicine... Accessed: December 2015
11) R. Pollock. Soft Tissue Sarcomas, A Volume in the American Cancer Society Atlas of
Clinical Oncology Series. 2012
Media Enquiries
Eisai
Cressida Robson / Ben Speller
+44(0)7908 314 155 / +44(0) 7951 078 795
Cressida_Robson@eisai.net
Ben_Speller@eisai.net
EmptyBreak:MARKER
Media Enquiries
Tonic Life Communications
Alex Davies / Emma Coughlan
+44 (0)7720 496 472 / +44(0) 7772 534 646
Alex.Davies@toniclc.com
Emma.Coughlan@toniclc.com
Andalucía
